Stockscreener 앱 받기
1.1992
0.00%
0.00
전일 마감가:
$1.1992
열려 있는:
$1.22
하루 거래량:
85,283
Relative Volume:
2.05
시가총액:
$35.51M
수익:
$2.96M
순이익/손실:
$-6.87M
주가수익비율:
-5.2139
EPS:
-0.23
순현금흐름:
$-7.49M
1주 성능:
+1.63%
1개월 성능:
-4.06%
6개월 성능:
+14.21%
1년 성능:
-16.14%
1일 변동 폭
$1.17
$1.28
1주일 범위
$1.17
$1.28
52주 변동 폭
$0.9257
$2.67
Dyadic International Inc De Stock (DYAI) Company Profile
명칭
Dyadic International Inc De
전화
561-743-8333
주소
1044 NORTH U.S. HIGHWAY ONE, JUPITER
DYAI을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
| 1.69 | 0 | 0 | 0 | 0 | 0.00 | |
GOODO
Gladstone Commercial Corporation
|
20.30 | 372.90M | 0 | 0 | 0 | 0.00 |
|
PSNYW
Polestar Automotive Holding Uk
|
0.159 | 349.69M | 2.07B | -1.42B | -1.37B | -0.6765 |
|
MOBBW
Mobilicom Limited Warrants
|
0.2267 | 318.40M | 0 | 0 | 0 | 0.00 |
|
JUNE
Dhandho Junoon Etf
|
10.63 | 205.55M | 0 | 0 | 0 | 0.00 |
|
SHMD
Schmid Group N V
|
3.985 | 157.18M | 0 | 0 | 0 | 0.00 |
Dyadic International Inc De Stock (DYAI) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2022-07-18 | 다운그레이드 | Dawson James | Buy → Neutral |
| 2021-12-17 | 개시 | H.C. Wainwright | Buy |
Dyadic International Inc De 주식(DYAI)의 최신 뉴스
Dyadic International, Inc. to Announce First Quarter 2025 Financial Results and Host Conference Call on May 14, 2025 - Nasdaq
Dyadic to Report First Quarter 2025 Financial Results on Wednesday, May 14, 2025 - Eagle-Tribune
Biotech Pioneer Dyadic Schedules Q1 2025 Earnings Call to Discuss Protein Manufacturing Progress - Stock Titan
Dyadic International director to retire in June - Investing.com Australia
Dyadic International director to retire in June By Investing.com - Investing.com India
Dyadic International Director Arindam Bose Announces Retirement - TipRanks
Dyadic International, Inc. (NASDAQ:DYAI) Sees Large Increase in Short Interest - Defense World
Captivision Inc. (NASDAQ:CAPTW) Short Interest Down 42.5% in March - Defense World
Short Interest in Capcom Co., Ltd. (OTCMKTS:CCOEF) Rises By 74.5% - Defense World
Dyadic International, Inc. CEO to Present at 2025 World Vaccine Congress on Advancements in Biomanufacturing for Vaccines - Nasdaq
Dyadic to Present at World Vaccine Congress | Washington - GlobeNewswire
Dyadic’s Earnings Call: Growth Amid Challenges - TipRanks
Dyadic Reports 2024 Year-End Financial Results and Business Updates - GlobeNewswire
Dyadic International Reports Strong 2024 Revenue Growth - TipRanks
Earnings call transcript: Dyadic Q4 2024 shows revenue beat, EPS miss - Investing.com Australia
Earnings call transcript: Dyadic Q4 2024 shows revenue beat, EPS miss By Investing.com - Investing.com South Africa
Dyadic International Inc reports results for the quarter ended December 31Earnings Summary - TradingView
DYADIC INTERNATIONAL Earnings Results: $DYAI Reports Quarterly Earnings - Nasdaq
Dyadic Boosts Revenue 20%, Lands Major Gates Foundation and CEPI Backing - Stock Titan
Specialty Enzymes Market Competitive Analysis and Growth Opportunities 2025-2032 - Newstrail
Dyadic International Inc expected to post a loss of 4 cents a shareEarnings Preview - TradingView
Dyadic (NASDAQ: DYAI) Secures $3M Gates Foundation Grant - openPR.com
Dyadic International Secures $4.5M for Vaccine Development - TipRanks
Breakthrough: New Dyadic Technology Slashes Vaccine Production Time from 6 Months to 35 Days - StockTitan
Dyadic International (DYAI) to Release Earnings on Wednesday - Defense World
Key Trend Shaping the Enzyme Stabilizer Market in 2025: Innovative Oral Enzyme Stabilizers Enhance Efficacy... - WhaTech
Short Interest in Dyadic International, Inc. (NASDAQ:DYAI) Declines By 19.9% - The AM Reporter
Dyadic to Report 2024 Full Year Financial Results and Host Conference call on Wednesday, March ... - Bluefield Daily Telegraph
Biotech Leader Dyadic Sets Date for 2024 Financial Results: Key Details for Investors - StockTitan
Industrial Enzymes Market Set For 7.1% Growth, Reaching $10.14 Billion By 2029 - WhaTech
Industrial Enzymes Global Industry Forecast Report and Company Analysis 2024-2030 Featuring BASF, Advanced Enzyme Technologies, Novozymes, DuPont Danisco, DSM, Kerry, Dyadic, Associated British Foods - GlobeNewswire Inc.
Industrial Enzymes Global Industry Forecast Report and - GlobeNewswire
Key Cellulase Market Trend 2025-2034: Product Innovation In The Cellulase Market In New Report - WhaTech
Dyadic to Attend Multiple Industry Events in March - Bluefield Daily Telegraph
Can These 3 Major Biotech Events Accelerate Dyadic's Market Position? - StockTitan
Jeans to Genes - Florida Trend
3 US Penny Stocks With Market Caps Over $40M To Consider - Simply Wall St
DYAI: Looking Toward Product Revenues - Zacks Small Cap Research
Global Enzymes Market Set for Robust Growth: Projected to Reach USD 20.4 Billion by 2029 As Discussed In Ne... - WhaTech
Food Enzymes Market to grow by USD 1.04 Billion from 2025-2029, driven by rising demand from beverage industry, Report on AI's role in market transformationTechnavio - The Malaysian Reserve
Food Enzymes Market Research Report 2025-2033, Featuring - GlobeNewswire
Enzymes Market Size, Top Companies, Sales Volume and Global Share Forecast Report - WICZ
Robust Growth in Protein Hydrolysis Enzymes Market: Insights on Market Dynamics, Key Players, and Emerging Trends - openPR
Proteases Global Market Report 2025: Robust Growth, Key Players, and Emerging Trends - openPR
Dyadic Advances Protein Platform with Key Launches, Gates Foundation Backs Vaccine Research - StockTitan
Dyadic International And 2 Other US Penny Stocks To Watch - Yahoo Finance
Alcohol and Starch Enzyme Market (2024-2032): Industry - openPR
Biocatalysts Market Competition & Segment Analysis - openPR
Hyperscale Data, Inc. (NYSEAMERICAN: GPUS) Announces Distribution of Series F Exchangeable Preferred Stock - Defense World
Specialty Enzymes Industry Research Report 2024: Global - GlobeNewswire
Cellulase Market 2024 Global Trends & 2033 Forecast: Growth Insights & Analysis In The Latest Report - WhaTech
Dyadic International Inc De (DYAI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Dyadic International Inc De 주식 (DYAI) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Kaye Jack | Director |
Mar 05 '25 |
Option Exercise |
1.33 |
30,000 |
39,900 |
87,166 |
| HERBST SETH | Director |
Jan 06 '25 |
Option Exercise |
0.97 |
25,000 |
24,250 |
180,759 |
0.52%
0.52%
자본화:
|
볼륨(24시간):